Back to Journals » Drug Design, Development and Therapy » Volume 8

Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway

Total article views   HTML views PDF downloads Totals
15,827 Dovepress* 14,870+ 1,672 16,542
PubMed Central* 957 407 1,364
Totals 15,827 2,079 17,906
*Since 12 December 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 0 3

View citations on PubMed Central and Google Scholar